Senators Question Pharmaceutical Companies’ Use of Telehealth Platforms
In October, four US Senators sent requests for more information to two of the largest pharmaceutical companies operating in the United States, Eli Lilly and Pfizer. The letters concerned both companies’ recent actions in establishing telehealth direct-to-consumer (DTC) platforms. As noted in a press release by Senator Dick Durbin (D-IL), these platforms operate by providing an opportunity for consumers to “talk to a doctor now” after they have read about the company’s medications and the potential benefits.